 This research study is intended to evaluate the safety and effectiveness of 3 different doses of BO-653, an investigational inhibitor of LDL cholesterol oxidation, when given orally twice a day compared to placebo an inactive substance in preventing restenosis closure of vessel within six months after stent implantation. Patients must be enrolled into this study within 24 hours after the stenting procedure. 